AGTC Pursues Gene Therapy on Multiple Tracks (OIS@ASRS 2016)

AGTC Pursues Gene Therapy on Multiple Tracks (OIS@ASRS 2016)

NEI Pursues Innovation on Multiple Tracks (OIS@AAO 2016)Подробнее

NEI Pursues Innovation on Multiple Tracks (OIS@AAO 2016)

AGTC Eyeing Multiple ShotsПодробнее

AGTC Eyeing Multiple Shots

AGTCПодробнее

AGTC

AGTCПодробнее

AGTC

AGTC Technology’s Effect on CaninesПодробнее

AGTC Technology’s Effect on Canines

AGTCПодробнее

AGTC

AGTC Pipeline: Four in Hand, One on the WayПодробнее

AGTC Pipeline: Four in Hand, One on the Way

AGTC XLRS Platform Well Tolerated (OIS@AAO 2016)Подробнее

AGTC XLRS Platform Well Tolerated (OIS@AAO 2016)

AGTCПодробнее

AGTC

AGTCПодробнее

AGTC

AGTCПодробнее

AGTC

OIS@ASRS 2016 Co-Chair Tarek Hassan on the Rise of the RetinaПодробнее

OIS@ASRS 2016 Co-Chair Tarek Hassan on the Rise of the Retina

Genetic and Regenerative Therapy Overview Presentation at Ophthalmology Innovation Summit 2019Подробнее

Genetic and Regenerative Therapy Overview Presentation at Ophthalmology Innovation Summit 2019

Adverum Biotechnologies Gains Momentum in Gene Therapy (OIS@AAO 2016)Подробнее

Adverum Biotechnologies Gains Momentum in Gene Therapy (OIS@AAO 2016)

FDA Approves Nation's First Gene Therapy For Rare Form Of BlindnessПодробнее

FDA Approves Nation's First Gene Therapy For Rare Form Of Blindness

Applied Genetic Technologies Corporation (AGTC) - OIS@AAO 2015Подробнее

Applied Genetic Technologies Corporation (AGTC) - OIS@AAO 2015

Seeking Answers on How to Pay for Innovation in Biopharma (OIS@ASRS 2016)Подробнее

Seeking Answers on How to Pay for Innovation in Biopharma (OIS@ASRS 2016)

Duker Speaks to Cost Concerns, Other Challenges Facing Retina (OIS@ASRS - 2016)Подробнее

Duker Speaks to Cost Concerns, Other Challenges Facing Retina (OIS@ASRS - 2016)